These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 9768717

  • 21. Nitric oxide synthase does not participate in negative inotropic effect of acetylcholine in frog heart.
    Méry PF, Hove-Madsen L, Chesnais JM, Hartzell HC, Fischmeister R.
    Am J Physiol; 1996 Apr; 270(4 Pt 2):H1178-88. PubMed ID: 8967355
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
    Ebihara Y, Karmazyn M.
    Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
    [Abstract] [Full Text] [Related]

  • 23. Reduced stretch-induced force response in failing human myocardium caused by impaired Na(+)-contraction coupling.
    von Lewinski D, Kockskämper J, Zhu D, Post H, Elgner A, Pieske B.
    Circ Heart Fail; 2009 Jan; 2(1):47-55. PubMed ID: 19808315
    [Abstract] [Full Text] [Related]

  • 24. Pertussis toxin-sensitive G proteins influence nitric oxide synthase III activity and protein levels in rat heart.
    Hare JM, Kim B, Flavahan NA, Ricker KM, Peng X, Colman L, Weiss RG, Kass DA.
    J Clin Invest; 1998 Mar 15; 101(6):1424-31. PubMed ID: 9502785
    [Abstract] [Full Text] [Related]

  • 25. Isoproterenol-induced heart failure in the rat is associated with nitric oxide-dependent functional alterations of cardiac function.
    Krenek P, Kmecova J, Kucerova D, Bajuszova Z, Musil P, Gazova A, Ochodnicky P, Klimas J, Kyselovic J.
    Eur J Heart Fail; 2009 Feb 15; 11(2):140-6. PubMed ID: 19168511
    [Abstract] [Full Text] [Related]

  • 26. Involvement of beta 3-adrenoceptor in altered beta-adrenergic response in senescent heart: role of nitric oxide synthase 1-derived nitric oxide.
    Birenbaum A, Tesse A, Loyer X, Michelet P, Andriantsitohaina R, Heymes C, Riou B, Amour J.
    Anesthesiology; 2008 Dec 15; 109(6):1045-53. PubMed ID: 19034101
    [Abstract] [Full Text] [Related]

  • 27. Effects of the beta3-adrenergic agonist BRL 37344 on endothelial nitric oxide synthase phosphorylation and force of contraction in human failing myocardium.
    Napp A, Brixius K, Pott C, Ziskoven C, Boelck B, Mehlhorn U, Schwinger RH, Bloch W.
    J Card Fail; 2009 Feb 15; 15(1):57-67. PubMed ID: 19181295
    [Abstract] [Full Text] [Related]

  • 28. Muscarinic and beta-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase.
    Vandecasteele G, Eschenhagen T, Scholz H, Stein B, Verde I, Fischmeister R.
    Nat Med; 1999 Mar 15; 5(3):331-4. PubMed ID: 10086391
    [Abstract] [Full Text] [Related]

  • 29. Modulation of mouse cardiac function in vivo by eNOS and ANP.
    Gyurko R, Kuhlencordt P, Fishman MC, Huang PL.
    Am J Physiol Heart Circ Physiol; 2000 Mar 15; 278(3):H971-81. PubMed ID: 10710367
    [Abstract] [Full Text] [Related]

  • 30. Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure.
    Steinfath M, Danielsen W, von der Leyen H, Mende U, Meyer W, Neumann J, Nose M, Reich T, Schmitz W, Scholz H.
    Br J Pharmacol; 1992 Feb 15; 105(2):463-9. PubMed ID: 1348446
    [Abstract] [Full Text] [Related]

  • 31. Disruption of inducible nitric oxide synthase improves beta-adrenergic inotropic responsiveness but not the survival of mice with cytokine-induced cardiomyopathy.
    Funakoshi H, Kubota T, Kawamura N, Machida Y, Feldman AM, Tsutsui H, Shimokawa H, Takeshita A.
    Circ Res; 2002 May 17; 90(9):959-65. PubMed ID: 12016261
    [Abstract] [Full Text] [Related]

  • 32. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats.
    Liu H, Ma Z, Lee SS.
    Gastroenterology; 2000 May 17; 118(5):937-44. PubMed ID: 10784593
    [Abstract] [Full Text] [Related]

  • 33. Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure: their relation to lesion site and beta-adrenergic receptor therapy.
    Fukuchi M, Hussain SN, Giaid A.
    Circulation; 1998 Jul 14; 98(2):132-9. PubMed ID: 9679719
    [Abstract] [Full Text] [Related]

  • 34. Effects of endothelial and inducible nitric oxide synthases inhibition on circulatory function in rats after myocardial infarction.
    Gaballa MA, Raya TE, Hoover CA, Goldman S.
    Cardiovasc Res; 1999 Jun 14; 42(3):627-35. PubMed ID: 10533602
    [Abstract] [Full Text] [Related]

  • 35. Inducible nitric oxide synthase attenuates adrenergic signaling in alcohol fed rats.
    Khanna D, Kan H, Fang Q, Xie Z, Underwood BL, Jain AC, Williams HJ, Finkel MS.
    J Cardiovasc Pharmacol; 2007 Dec 14; 50(6):692-6. PubMed ID: 18091587
    [Abstract] [Full Text] [Related]

  • 36. Nitric oxide modulates myocardial oxygen consumption in the failing heart.
    Chen Y, Traverse JH, Du R, Hou M, Bache RJ.
    Circulation; 2002 Jul 09; 106(2):273-9. PubMed ID: 12105170
    [Abstract] [Full Text] [Related]

  • 37. (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through beta2 -adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling.
    Molenaar P, Savarimuthu SM, Sarsero D, Chen L, Semmler AB, Carle A, Yang I, Bartel S, Vetter D, Beyerdörfer I, Krause EG, Kaumann AJ.
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar 09; 375(1):11-28. PubMed ID: 17295024
    [Abstract] [Full Text] [Related]

  • 38. Upregulation of the nitric oxide-cGMP pathway in aged myocardium: physiological response to l-arginine.
    Zieman SJ, Gerstenblith G, Lakatta EG, Rosas GO, Vandegaer K, Ricker KM, Hare JM.
    Circ Res; 2001 Jan 19; 88(1):97-102. PubMed ID: 11139480
    [Abstract] [Full Text] [Related]

  • 39. Positive and negative inotropic effects of DL-sotalol and D-sotalol in failing and nonfailing human myocardium under physiological experimental conditions.
    Holubarsch C, Schneider R, Pieske B, Ruf T, Hasenfuss G, Fraedrich G, Posival H, Just H.
    Circulation; 1995 Nov 15; 92(10):2904-10. PubMed ID: 7586258
    [Abstract] [Full Text] [Related]

  • 40. Altered contractile response due to increased beta3-adrenoceptor stimulation in diabetic cardiomyopathy: the role of nitric oxide synthase 1-derived nitric oxide.
    Amour J, Loyer X, Le Guen M, Mabrouk N, David JS, Camors E, Carusio N, Vivien B, Andriantsitohaina R, Heymes C, Riou B.
    Anesthesiology; 2007 Sep 15; 107(3):452-60. PubMed ID: 17721248
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.